A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Clinical trial NCT05428345 · RECRUITING
Trial details
- NCT number
- NCT05428345
- Sponsor
- Takeda
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-25
- Primary completion
- 2027-11-30
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.